JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
Equities
000623
CNE000000719
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.99 CNY | +0.20% |
|
-0.60% | -0.99% |
| 04-29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
ETFs positioned on Jilin Aodong Pharmaceutical Group Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 112 M€ | +4.06% | - | |
| 0.00% | 7 M€ | +5.02% | - | |
| 0.00% | 32 M€ | +7.48% | - | |
| 0.00% | 34 M€ | +3.39% | - |
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows:
- sale of pharmaceutical products (89.4%);
- sale of food products (6.8%);
- other (3.8%).
All sales are in China.
Sector
Pharmaceuticals
Calendar
17/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.99
CNY
Average target price
22.67
CNY
Spread / Average Target
+51.23%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -0.99% | 2.48B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
- Stock Market
- Equities
- 000623 Stock
- Funds and ETFs Jilin Aodong Pharmaceutical Group Co., Ltd.
